25 XP   0   0   10

Bioptik Technology
Buy, Hold or Sell?

Let's analyse Bioptik together

PenkeI guess you are interested in Bioptik Technology. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioptik Technology. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bioptik Technology

I send you an email if I find something interesting about Bioptik Technology.

Quick analysis of Bioptik (30 sec.)










What can you expect buying and holding a share of Bioptik? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
64.3%

What is your share worth?

Current worth
NT$15.56
Expected worth in 1 year
NT$17.56
How sure are you?
78.6%

+ What do you gain per year?

Total Gains per Share
NT$2.01
Return On Investment
5.8%

For what price can you sell your share?

Current Price per Share
NT$34.45
Expected price per share
NT$32.75 - NT$39.00
How sure are you?
50%

1. Valuation of Bioptik (5 min.)




Live pricePrice per Share (EOD)

NT$34.45

Intrinsic Value Per Share

NT$41.75 - NT$49.88

Total Value Per Share

NT$57.30 - NT$65.43

2. Growth of Bioptik (5 min.)




Is Bioptik growing?

Current yearPrevious yearGrowGrow %
How rich?$25.3m$21.2m$2.6m11.2%

How much money is Bioptik making?

Current yearPrevious yearGrowGrow %
Making money$657.8k$372.2k$285.6k43.4%
Net Profit Margin9.6%5.4%--

How much money comes from the company's main activities?

3. Financial Health of Bioptik (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#196 / 332

Most Revenue
#204 / 332

Most Profit
#97 / 332

What can you expect buying and holding a share of Bioptik? (5 min.)

Welcome investor! Bioptik's management wants to use your money to grow the business. In return you get a share of Bioptik.

What can you expect buying and holding a share of Bioptik?

First you should know what it really means to hold a share of Bioptik. And how you can make/lose money.

Speculation

The Price per Share of Bioptik is NT$34.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioptik.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioptik, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$15.56. Based on the TTM, the Book Value Change Per Share is NT$0.50 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioptik.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.020.1%0.010.0%0.010.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.020.1%0.020.0%0.000.0%0.030.1%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.020.1%0.020.0%0.010.0%0.040.1%0.040.1%
Usd Price Per Share0.99-1.01-0.79-0.86-0.86-
Price to Earnings Ratio12.26-30.27-131.66-69.29-69.29-
Price-to-Total Gains Ratio49.27-73.99-22.83-30.66-30.66-
Price to Book Ratio2.07-2.24-1.96-2.02-2.02-
Price-to-Total Gains Ratio49.27-73.99-22.83-30.66-30.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.057615
Number of shares945
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.020.04
Gains per Quarter (945 shares)14.5637.90
Gains per Year (945 shares)58.22151.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10584823129142
2011610645258294
3017516468387446
4023322291516598
50291280113645750
60349338136774902
704083961599031054
8046645418110321206
9052451220411601358
10058257022712891510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%12.02.00.085.7%12.02.00.085.7%12.02.00.085.7%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%11.03.00.078.6%11.03.00.078.6%11.03.00.078.6%
Dividend per Share0.00.04.00.0%7.00.05.058.3%9.00.05.064.3%9.00.05.064.3%9.00.05.064.3%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%11.03.00.078.6%11.03.00.078.6%11.03.00.078.6%

Fundamentals of Bioptik

About Bioptik Technology

Bioptik Technology Incorporation engages in the production and sale of medical devices and reagents worldwide. It offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. The company also provides skin care products and dietary supplements, as well as biodiesel products. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.

Fundamental data was last updated by Penke on 2024-04-20 15:08:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bioptik Technology.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioptik earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Bioptik to the Medical Devices industry mean.
  • A Net Profit Margin of 14.1% means that NT$0.14 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioptik Technology:

  • The MRQ is 14.1%. The company is making a huge profit. +2
  • The TTM is 9.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ14.1%TTM9.6%+4.4%
TTM9.6%YOY5.4%+4.3%
TTM9.6%5Y2.7%+6.9%
5Y2.7%10Y2.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.1%-11.2%+25.3%
TTM9.6%-20.2%+29.8%
YOY5.4%-13.4%+18.8%
5Y2.7%-20.6%+23.3%
10Y2.7%-25.0%+27.7%
1.1.2. Return on Assets

Shows how efficient Bioptik is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioptik to the Medical Devices industry mean.
  • 2.3% Return on Assets means that Bioptik generated NT$0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioptik Technology:

  • The MRQ is 2.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM1.4%+0.9%
TTM1.4%YOY0.8%+0.7%
TTM1.4%5Y0.5%+0.9%
5Y0.5%10Y0.5%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-4.0%+6.3%
TTM1.4%-4.6%+6.0%
YOY0.8%-4.3%+5.1%
5Y0.5%-3.9%+4.4%
10Y0.5%-4.9%+5.4%
1.1.3. Return on Equity

Shows how efficient Bioptik is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioptik to the Medical Devices industry mean.
  • 4.2% Return on Equity means Bioptik generated NT$0.04 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioptik Technology:

  • The MRQ is 4.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM2.7%+1.5%
TTM2.7%YOY1.7%+1.0%
TTM2.7%5Y1.1%+1.6%
5Y1.1%10Y1.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2%-4.1%+8.3%
TTM2.7%-5.7%+8.4%
YOY1.7%-5.2%+6.9%
5Y1.1%-6.1%+7.2%
10Y1.1%-6.9%+8.0%

1.2. Operating Efficiency of Bioptik Technology.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioptik is operating .

  • Measures how much profit Bioptik makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioptik to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioptik Technology:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.1%-2.1%
TTM2.1%YOY3.8%-1.6%
TTM2.1%5Y1.3%+0.8%
5Y1.3%10Y1.3%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.5%+24.5%
TTM2.1%-17.1%+19.2%
YOY3.8%-13.7%+17.5%
5Y1.3%-19.6%+20.9%
10Y1.3%-24.8%+26.1%
1.2.2. Operating Ratio

Measures how efficient Bioptik is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are NT$1.48 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Bioptik Technology:

  • The MRQ is 1.479. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.616. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.479TTM1.616-0.137
TTM1.616YOY1.739-0.123
TTM1.6165Y1.738-0.122
5Y1.73810Y1.7380.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4791.452+0.027
TTM1.6161.447+0.169
YOY1.7391.428+0.311
5Y1.7381.432+0.306
10Y1.7381.374+0.364

1.3. Liquidity of Bioptik Technology.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioptik is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.69 means the company has NT$1.69 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioptik Technology:

  • The MRQ is 1.688. The company is able to pay all its short-term debts. +1
  • The TTM is 1.589. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.688TTM1.589+0.099
TTM1.589YOY1.384+0.205
TTM1.5895Y1.497+0.092
5Y1.49710Y1.4970.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6882.688-1.000
TTM1.5892.711-1.122
YOY1.3843.504-2.120
5Y1.4973.621-2.124
10Y1.4973.475-1.978
1.3.2. Quick Ratio

Measures if Bioptik is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioptik to the Medical Devices industry mean.
  • A Quick Ratio of 0.18 means the company can pay off NT$0.18 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioptik Technology:

  • The MRQ is 0.179. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.285. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.285-0.106
TTM0.285YOY0.524-0.239
TTM0.2855Y0.552-0.267
5Y0.55210Y0.5520.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1791.521-1.342
TTM0.2851.665-1.380
YOY0.5242.144-1.620
5Y0.5522.307-1.755
10Y0.5522.370-1.818

1.4. Solvency of Bioptik Technology.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioptik assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioptik to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.45 means that Bioptik assets are financed with 45.0% credit (debt) and the remaining percentage (100% - 45.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioptik Technology:

  • The MRQ is 0.450. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.470. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.450TTM0.470-0.020
TTM0.470YOY0.544-0.074
TTM0.4705Y0.509-0.039
5Y0.50910Y0.5090.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4500.402+0.048
TTM0.4700.391+0.079
YOY0.5440.334+0.210
5Y0.5090.442+0.067
10Y0.5090.460+0.049
1.4.2. Debt to Equity Ratio

Measures if Bioptik is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioptik to the Medical Devices industry mean.
  • A Debt to Equity ratio of 82.2% means that company has NT$0.82 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioptik Technology:

  • The MRQ is 0.822. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.894. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.822TTM0.894-0.072
TTM0.894YOY1.201-0.307
TTM0.8945Y1.053-0.159
5Y1.05310Y1.0530.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8220.576+0.246
TTM0.8940.581+0.313
YOY1.2010.480+0.721
5Y1.0530.623+0.430
10Y1.0530.692+0.361

2. Market Valuation of Bioptik Technology

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Bioptik generates.

  • Above 15 is considered overpriced but always compare Bioptik to the Medical Devices industry mean.
  • A PE ratio of 12.26 means the investor is paying NT$12.26 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioptik Technology:

  • The EOD is 13.134. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.257. Based on the earnings, the company is underpriced. +1
  • The TTM is 30.273. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.134MRQ12.257+0.877
MRQ12.257TTM30.273-18.016
TTM30.273YOY131.665-101.392
TTM30.2735Y69.294-39.021
5Y69.29410Y69.2940.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD13.134-1.025+14.159
MRQ12.257-1.714+13.971
TTM30.273-2.286+32.559
YOY131.665-2.889+134.554
5Y69.294-2.379+71.673
10Y69.294-2.013+71.307
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioptik Technology:

  • The EOD is 8.181. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.635. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.226. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.181MRQ7.635+0.546
MRQ7.635TTM12.226-4.591
TTM12.226YOY9.666+2.560
TTM12.2265Y11.782+0.444
5Y11.78210Y11.7820.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD8.181-0.914+9.095
MRQ7.635-1.578+9.213
TTM12.226-3.116+15.342
YOY9.666-6.325+15.991
5Y11.782-5.399+17.181
10Y11.782-5.369+17.151
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioptik is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.07 means the investor is paying NT$2.07 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioptik Technology:

  • The EOD is 2.215. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.067. Based on the equity, the company is underpriced. +1
  • The TTM is 2.241. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.215MRQ2.067+0.148
MRQ2.067TTM2.241-0.175
TTM2.241YOY1.955+0.286
TTM2.2415Y2.019+0.222
5Y2.01910Y2.0190.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.2152.027+0.188
MRQ2.0672.380-0.313
TTM2.2412.470-0.229
YOY1.9553.182-1.227
5Y2.0193.918-1.899
10Y2.0194.300-2.281
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bioptik Technology compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6530.502+30%0.110+494%1.111-41%1.111-41%
Book Value Per Share--15.55614.737+6%13.090+19%13.852+12%13.852+12%
Current Ratio--1.6881.589+6%1.384+22%1.497+13%1.497+13%
Debt To Asset Ratio--0.4500.470-4%0.544-17%0.509-12%0.509-12%
Debt To Equity Ratio--0.8220.894-8%1.201-32%1.053-22%1.053-22%
Dividend Per Share----0%0.205-100%0.195-100%0.195-100%
Eps--0.6560.404+62%0.229+187%0.158+316%0.158+316%
Free Cash Flow Per Share--1.0530.825+28%0.179+487%0.244+331%0.244+331%
Free Cash Flow To Equity Per Share--1.0530.583+81%0.011+9135%0.068+1449%0.068+1449%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--49.879--------
Intrinsic Value_10Y_min--41.745--------
Intrinsic Value_1Y_max--1.543--------
Intrinsic Value_1Y_min--1.514--------
Intrinsic Value_3Y_max--7.270--------
Intrinsic Value_3Y_min--6.887--------
Intrinsic Value_5Y_max--16.171--------
Intrinsic Value_5Y_min--14.783--------
Market Cap1825195450.000+7%1703339150.0001746386212.500-2%1356313600.000+26%1483657217.857+15%1483657217.857+15%
Net Profit Margin--0.1410.096+46%0.054+161%0.027+422%0.027+422%
Operating Margin---0.021-100%0.038-100%0.013-100%0.013-100%
Operating Ratio--1.4791.616-8%1.739-15%1.738-15%1.738-15%
Pb Ratio2.215+7%2.0672.241-8%1.955+6%2.019+2%2.019+2%
Pe Ratio13.134+7%12.25730.273-60%131.665-91%69.294-82%69.294-82%
Price Per Share34.450+7%32.15032.963-2%25.600+26%28.004+15%28.004+15%
Price To Free Cash Flow Ratio8.181+7%7.63512.226-38%9.666-21%11.782-35%11.782-35%
Price To Total Gains Ratio52.794+7%49.26973.990-33%22.834+116%30.659+61%30.659+61%
Quick Ratio--0.1790.285-37%0.524-66%0.552-68%0.552-68%
Return On Assets--0.0230.014+61%0.008+193%0.005+325%0.005+325%
Return On Equity--0.0420.027+56%0.017+147%0.011+291%0.011+291%
Total Gains Per Share--0.6530.502+30%0.315+107%1.306-50%1.306-50%
Usd Book Value--25301405.00023970368.125+6%21290941.200+19%22530221.257+12%22530221.257+12%
Usd Book Value Change Per Share--0.0200.015+30%0.003+494%0.034-41%0.034-41%
Usd Book Value Per Share--0.4780.452+6%0.402+19%0.425+12%0.425+12%
Usd Dividend Per Share----0%0.006-100%0.006-100%0.006-100%
Usd Eps--0.0200.012+62%0.007+187%0.005+316%0.005+316%
Usd Free Cash Flow--1712353.9001342449.600+28%291473.475+487%397097.921+331%397097.921+331%
Usd Free Cash Flow Per Share--0.0320.025+28%0.006+487%0.007+331%0.007+331%
Usd Free Cash Flow To Equity Per Share--0.0320.018+81%0.000+9135%0.002+1449%0.002+1449%
Usd Market Cap56033500.315+7%52292511.90553614056.724-2%41638827.520+26%45548276.588+15%45548276.588+15%
Usd Price Per Share1.058+7%0.9871.012-2%0.786+26%0.860+15%0.860+15%
Usd Profit--1066610.100657824.250+62%372222.150+187%256513.850+316%256513.850+316%
Usd Revenue--7570006.0006358745.175+19%5892504.275+28%5656242.557+34%5656242.557+34%
Usd Total Gains Per Share--0.0200.015+30%0.010+107%0.040-50%0.040-50%
 EOD+4 -4MRQTTM+27 -6YOY+29 -65Y+25 -1010Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Bioptik Technology based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.134
Price to Book Ratio (EOD)Between0-12.215
Net Profit Margin (MRQ)Greater than00.141
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.179
Current Ratio (MRQ)Greater than11.688
Debt to Asset Ratio (MRQ)Less than10.450
Debt to Equity Ratio (MRQ)Less than10.822
Return on Equity (MRQ)Greater than0.150.042
Return on Assets (MRQ)Greater than0.050.023
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Bioptik Technology based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.328
Ma 20Greater thanMa 5035.005
Ma 50Greater thanMa 10036.601
Ma 100Greater thanMa 20034.535
OpenGreater thanClose34.400
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets1,497,706
Total Liabilities673,556
Total Stockholder Equity819,341
 As reported
Total Liabilities 673,556
Total Stockholder Equity+ 819,341
Total Assets = 1,497,706

Assets

Total Assets1,497,706
Total Current Assets872,243
Long-term Assets625,463
Total Current Assets
Cash And Cash Equivalents 368,612
Short-term Investments 25,514
Net Receivables 66,988
Inventory 235,022
Total Current Assets  (as reported)872,243
Total Current Assets  (calculated)696,136
+/- 176,107
Long-term Assets
Property Plant Equipment 524,800
Long-term Assets Other 6,395
Long-term Assets  (as reported)625,463
Long-term Assets  (calculated)531,195
+/- 94,268

Liabilities & Shareholders' Equity

Total Current Liabilities516,762
Long-term Liabilities156,794
Total Stockholder Equity819,341
Total Current Liabilities
Short Long Term Debt 365,673
Accounts payable 83,290
Other Current Liabilities 9,524
Total Current Liabilities  (as reported)516,762
Total Current Liabilities  (calculated)458,487
+/- 58,275
Long-term Liabilities
Long term Debt 152,778
Capital Lease Obligations Min Short Term Debt4,791
Long-term Liabilities Other 44
Long-term Liabilities  (as reported)156,794
Long-term Liabilities  (calculated)157,613
+/- 819
Total Stockholder Equity
Retained Earnings 1,640
Total Stockholder Equity (as reported)819,341
Total Stockholder Equity (calculated)1,640
+/- 817,701
Other
Capital Stock529,808
Common Stock Shares Outstanding 52,981
Net Debt 149,839
Net Invested Capital 1,337,792
Net Working Capital 355,481
Property Plant and Equipment Gross 524,800



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
1,413,286
1,473,757
1,476,281
1,534,772
1,557,169
1,523,922
1,515,117
1,511,321
1,544,931
1,515,231
1,479,052
1,424,995
1,489,805
1,497,706
1,497,7061,489,8051,424,9951,479,0521,515,2311,544,9311,511,3211,515,1171,523,9221,557,1691,534,7721,476,2811,473,7571,413,286
   > Total Current Assets 
732,071
747,225
755,532
779,834
842,399
860,939
865,706
868,600
906,858
870,782
840,212
782,382
851,309
872,243
872,243851,309782,382840,212870,782906,858868,600865,706860,939842,399779,834755,532747,225732,071
       Cash And Cash Equivalents 
248,820
258,005
257,678
180,753
145,241
103,883
76,334
270,447
297,494
310,533
352,903
338,668
330,728
368,612
368,612330,728338,668352,903310,533297,494270,44776,334103,883145,241180,753257,678258,005248,820
       Short-term Investments 
158,687
151,713
146,876
141,443
224,405
240,965
246,506
51,695
23,653
22,078
20,838
20,690
20,228
25,514
25,51420,22820,69020,83822,07823,65351,695246,506240,965224,405141,443146,876151,713158,687
       Net Receivables 
136,996
158,984
178,746
263,116
280,376
297,497
280,506
233,275
245,393
227,026
175,215
178,020
92,225
66,988
66,98892,225178,020175,215227,026245,393233,275280,506297,497280,376263,116178,746158,984136,996
       Inventory 
183,296
174,075
167,067
187,815
186,862
213,360
256,694
305,974
335,056
306,114
285,567
239,831
245,718
235,022
235,022245,718239,831285,567306,114335,056305,974256,694213,360186,862187,815167,067174,075183,296
   > Long-term Assets 
681,215
726,532
720,749
754,938
714,770
662,983
649,411
642,721
638,073
644,449
638,840
642,613
638,496
625,463
625,463638,496642,613638,840644,449638,073642,721649,411662,983714,770754,938720,749726,532681,215
       Property Plant Equipment 
567,092
558,537
552,416
547,508
544,231
540,997
534,871
529,144
525,296
525,098
520,262
524,603
526,811
524,800
524,800526,811524,603520,262525,098525,296529,144534,871540,997544,231547,508552,416558,537567,092
       Other Assets 
15,893
13,740
15,376
16,359
17,797
16,423
18,282
15,790
10,117
14,877
15,945
12,571
0
0
0012,57115,94514,87710,11715,79018,28216,42317,79716,35915,37613,74015,893
> Total Liabilities 
717,170
738,100
740,497
756,615
820,293
829,383
842,600
836,460
836,072
797,404
732,338
662,262
700,227
673,556
673,556700,227662,262732,338797,404836,072836,460842,600829,383820,293756,615740,497738,100717,170
   > Total Current Liabilities 
448,843
478,556
491,221
517,609
591,256
610,676
634,022
637,993
647,565
618,164
560,596
493,364
537,631
516,762
516,762537,631493,364560,596618,164647,565637,993634,022610,676591,256517,609491,221478,556448,843
       Short Long Term Debt 
344,352
340,101
353,212
358,698
425,984
425,973
437,354
467,239
473,710
480,127
468,959
394,453
387,561
365,673
365,673387,561394,453468,959480,127473,710467,239437,354425,973425,984358,698353,212340,101344,352
       Accounts payable 
68,188
97,790
114,310
135,262
143,810
158,408
149,944
160,894
183,546
125,151
75,265
75,459
92,948
83,290
83,29092,94875,45975,265125,151183,546160,894149,944158,408143,810135,262114,31097,79068,188
       Other Current Liabilities 
29,667
29,754
25,883
31,299
36,140
40,941
48,178
46,193
44,002
63,474
44,263
40,533
3,961
9,524
9,5243,96140,53344,26363,47444,00246,19348,17840,94136,14031,29925,88329,75429,667
   > Long-term Liabilities 
268,327
259,544
249,276
239,006
229,037
218,707
208,578
198,467
188,507
179,240
171,742
168,898
162,596
156,794
156,794162,596168,898171,742179,240188,507198,467208,578218,707229,037239,006249,276259,544268,327
       Long term Debt 
257,367
248,421
239,474
230,528
221,581
212,635
203,688
194,742
185,962
177,182
168,402
163,194
157,986
152,778
152,778157,986163,194168,402177,182185,962194,742203,688212,635221,581230,528239,474248,421257,367
       Capital Lease Obligations Min Short Term Debt
16,064
16,252
14,947
13,643
12,879
11,512
10,128
8,744
6,842
5,557
6,534
7,441
6,118
4,791
4,7916,1187,4416,5345,5576,8428,74410,12811,51212,87913,64314,94716,25216,064
       Other Liabilities 
98
97
97
97
97
101
101
101
101
588
588
2,087
0
0
002,0875885881011011011019797979798
       Long-term Liabilities Other 
92
91
91
91
91
95
95
95
95
44
44
44
44
44
4444444444959595959191919192
> Total Stockholder Equity
692,356
730,496
731,001
772,077
730,579
690,252
668,855
671,464
705,685
715,133
741,145
757,422
784,548
819,341
819,341784,548757,422741,145715,133705,685671,464668,855690,252730,579772,077731,001730,496692,356
   Common Stock
526,597
526,597
526,597
526,597
526,597
526,597
526,597
526,597
517,297
517,297
524,279
524,279
0
0
00524,279524,279517,297517,297526,597526,597526,597526,597526,597526,597526,597526,597
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
-23,493
31,083
29,492
66,314
29,175
-16,361
-25,200
-23,601
-18,308
-25,497
-46,742
-17,609
0
0
00-17,609-46,742-25,497-18,308-23,601-25,200-16,36129,17566,31429,49231,083-23,493



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue828,501
Cost of Revenue-588,962
Gross Profit239,539239,539
 
Operating Income (+$)
Gross Profit239,539
Operating Expense-738,255
Operating Income90,246-498,716
 
Operating Expense (+$)
Research Development71,466
Selling General Administrative77,827
Selling And Marketing Expenses0
Operating Expense738,255149,293
 
Net Interest Income (+$)
Interest Income10,699
Interest Expense-10,996
Other Finance Cost-0
Net Interest Income-297
 
Pretax Income (+$)
Operating Income90,246
Net Interest Income-297
Other Non-Operating Income Expenses0
Income Before Tax (EBT)106,47090,246
EBIT - interestExpense = -10,996
85,710
96,706
Interest Expense10,996
Earnings Before Interest and Taxes (EBIT)0117,466
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax106,470
Tax Provision-21,887
Net Income From Continuing Ops84,58384,583
Net Income85,710
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0297
 

Technical Analysis of Bioptik
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioptik. The general trend of Bioptik is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioptik's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bioptik Technology.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 38.35 < 38.50 < 39.00.

The bearish price targets are: 34.20 > 32.80 > 32.75.

Tweet this
Bioptik Technology Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bioptik Technology. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bioptik Technology Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bioptik Technology. The current macd is -0.61568574.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioptik price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bioptik. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bioptik price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bioptik Technology Daily Moving Average Convergence/Divergence (MACD) ChartBioptik Technology Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bioptik Technology. The current adx is 17.95.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bioptik shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bioptik Technology Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bioptik Technology. The current sar is 36.74.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bioptik Technology Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bioptik Technology. The current rsi is 43.33. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Bioptik Technology Daily Relative Strength Index (RSI) ChartBioptik Technology Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bioptik Technology. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bioptik price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Bioptik Technology Daily Stochastic Oscillator ChartBioptik Technology Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bioptik Technology. The current cci is -55.45410275.

Bioptik Technology Daily Commodity Channel Index (CCI) ChartBioptik Technology Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bioptik Technology. The current cmo is -11.42660207.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bioptik Technology Daily Chande Momentum Oscillator (CMO) ChartBioptik Technology Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bioptik Technology. The current willr is -69.64285714.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bioptik is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bioptik Technology Daily Williams %R ChartBioptik Technology Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bioptik Technology.

Bioptik Technology Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bioptik Technology. The current atr is 1.1486874.

Bioptik Technology Daily Average True Range (ATR) ChartBioptik Technology Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bioptik Technology. The current obv is 7,847,757.

Bioptik Technology Daily On-Balance Volume (OBV) ChartBioptik Technology Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bioptik Technology. The current mfi is 56.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bioptik Technology Daily Money Flow Index (MFI) ChartBioptik Technology Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bioptik Technology.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Bioptik Technology Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bioptik Technology based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.328
Ma 20Greater thanMa 5035.005
Ma 50Greater thanMa 10036.601
Ma 100Greater thanMa 20034.535
OpenGreater thanClose34.400
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bioptik with someone you think should read this too:
  • Are you bullish or bearish on Bioptik? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioptik? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bioptik Technology

I send you an email if I find something interesting about Bioptik Technology.


Comments

How you think about this?

Leave a comment

Stay informed about Bioptik Technology.

Receive notifications about Bioptik Technology in your mailbox!